Erleada 240 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F65M3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,245
Award facts
- Contract value 100% obligated
- $23,245.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,245.17 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) with a firm fixed-price contract structure. The award was made on January 13, 2026, with an ultimate completion date of February 4, 2026, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent organization being Cencora, Inc. (doing business as AmerisourceBergen). This delivery order is issued under a significantly larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which authorizes comprehensive pharmaceutical supply across multiple therapeutic domains to support military healthcare systems globally.
AmerisourceBergen's IDC with DLA encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The company has demonstrated consistent capability in fulfilling federal medical procurement requirements through multiple competitive awards, serving critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Erleada, a prescription oncology medication, exemplifies the company's role in providing essential pharmaceutical commodities to support military treatment facilities and veteran healthcare programs. The non-set-aside competitive award status reflects AmerisourceBergen's ability to compete effectively against other qualified pharmaceutical distributors in the open marketplace for federal contracts.
Quick answers
Who was awarded contract SPE2DR26F65M3?
SPE2DR26F65M3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F65M3 worth?
The government has obligated $23,245 on SPE2DR26F65M3.
Is contract SPE2DR26F65M3 an order under another contract?
Yes. SPE2DR26F65M3 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F65M3 competed?
The extent of competition for SPE2DR26F65M3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award